Granules India Ltd on Thursday said its wholly-owned subsidiary Granules Pharmaceuticals Inc. has entered into an agreement to acquire 12.5% stake in US-based drug maker USpharma Inc. but did not disclose the amount.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
